References
- Ball S C, Abraha A, et al. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 2003; 77: 1021–1038
- Brenner B, Turner D, et al. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 2003; 17: F1–F5
- Calazans A, Brindeiro R, et al. Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism. J Infect Dis 2005; 191: 1961–1970
- Laeyendecker O, Li X, et al. The effect of HIV subtype on rapid disease progression in Rakai. Uganda 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO, 2006
- Ranga U, Shankarappa R, et al. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004; 78: 2586–2590
- Siddappa N B, Dash P K, et al. Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J Clin Microbiol 2004; 42: 2742–2751
- Soares M A, De Oliveira T, et al. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 2003; 17: 11–21